Metoclopramide (Page 7 of 7)

Package/Label Display Panel

NDC 0093-2204-01

Metoclopramide Tablets, USP

5 mg

PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 Tablets

5mg 100s 8/2021
(click image for full-size original)

Package/Label Display Panel

NDC 0093-2203-01

Metoclopramide Tablets, USP

10 mg

PHARMACIST: Dispense the accompanying Medication Guide to each patient.

Rx only

100 Tablets

10 mg 100s 8/2021
(click image for full-size original)
METOCLOPRAMIDE
metoclopramide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-2204
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METOCLOPRAMIDE HYDROCHLORIDE (METOCLOPRAMIDE) METOCLOPRAMIDE 5 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code TV;2204
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-2204-01 100 TABLET in 1 BOTTLE None
2 NDC:0093-2204-05 500 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072801 07/01/1993
METOCLOPRAMIDE
metoclopramide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-2203
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METOCLOPRAMIDE HYDROCHLORIDE (METOCLOPRAMIDE) METOCLOPRAMIDE 10 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color white Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code TEVA;2203
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-2203-01 100 TABLET in 1 BOTTLE None
2 NDC:0093-2203-05 500 TABLET in 1 BOTTLE None
3 NDC:0093-2203-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070184 09/30/1990
Labeler — Teva Pharmaceuticals USA, Inc. (001627975)

Revised: 08/2021 Teva Pharmaceuticals USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.